Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 54, pseudogene (RNU1-54P)
- Target
- RNU1-54P
- Molecular classification
- Other (Pseudogene, non-coding RNA, small nuclear RNA family member)
01
Overview
RNU1-54P is a non-coding RNA pseudogene belonging to the U1 small nuclear RNA (snRNA) gene family. Unlike its canonical counterparts (such as RNU1-1), which encode U1 snRNA essential for pre-mRNA splicing in the spliceosome, RNU1-54P does not produce a functional product and is considered non-coding. Pseudogenes such as RNU1-54P typically arise from duplication or mutation of ancestral genes and have lost their functional capacity for transcription or translation. As such, RNU1-54P does not serve any known direct role in gene expression, splicing, cellular regulation, or disease and is not considered a therapeutic or biological target. RNU1-54P is a pseudogene of the U1 snRNA family, is not a functional gene or drug target, has no known biological or disease associations, and should not be listed among therapeutic targets.
- Other names
- RNU1-54PRNA, U1 small nuclear 54, pseudogene
02
Mechanism of action
None known or relevant
03
Biological functions
None known for the pseudogene itself. Pseudogenes, by definition, do not encode functional RNAs or proteins.
04
Disease associations
None specific. No direct, documented relationship with human disease for this pseudogene.
05
Safety considerations
None known or relevant
06
Interacting drugs
None known or relevant
07
Biomarkers
None known or relevant
Beyond the preview
Go deeper on RNA, U1 small nuclear 54, pseudogene (RNU1-54P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U1 small nuclear 54, pseudogene (RNU1-54P).